Liminal BioSciences (NASDAQ:LMNL) Downgraded by Zacks Investment Research to Hold

Liminal BioSciences} stock has undergone multiple analysts rating changes in the recent past.  Liminal BioSciences Downgraded by Zacks Investment Research on 10/20/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Liminal BioSciences (NASDAQ:LMNL) Downgraded by Zacks Investment Research to Hold